Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Finished Goods (2016 - 2024)

Historic Finished Goods for Zepp Health (ZEPP) over the last 9 years, with Q4 2024 value amounting to $45.8 million.

  • Zepp Health's Finished Goods fell 3096.03% to $45.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $45.8 million, marking a year-over-year decrease of 3096.03%. This contributed to the annual value of $45.8 million for FY2024, which is 3192.15% down from last year.
  • Zepp Health's Finished Goods amounted to $45.8 million in Q4 2024, which was down 3096.03% from $66.4 million recorded in Q4 2023.
  • Zepp Health's 5-year Finished Goods high stood at $116.1 million for Q4 2021, and its period low was $45.8 million during Q4 2024.
  • For the 5-year period, Zepp Health's Finished Goods averaged around $86.4 million, with its median value being $92.1 million (2020).
  • Per our database at Business Quant, Zepp Health's Finished Goods soared by 4697.8% in 2020 and then crashed by 4055.45% in 2023.
  • Zepp Health's Finished Goods (Quarter) stood at $92.1 million in 2020, then increased by 26.03% to $116.1 million in 2021, then dropped by 3.84% to $111.7 million in 2022, then plummeted by 40.55% to $66.4 million in 2023, then crashed by 30.96% to $45.8 million in 2024.
  • Its Finished Goods stands at $45.8 million for Q4 2024, versus $66.4 million for Q4 2023 and $111.7 million for Q4 2022.